How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole

calendar_today December 6, 2022 person lsc-webmaster domain pulmocide

Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic […]

open_in_new Read original post